Pill Identifier App

130 (Mycophenolate mofetil 250 mg)

Pill imprint 130 has been identified as Mycophenolate mofetil 250 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; organ transplant, rejection prophylaxis; systemic lupus erythematosus; uveitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 130

Mycophenolate mofetil 250 mg 130
Mycophenolate mofetil
Imprint:
130
Strength:
250 mg
Color:
Blue & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0130
Inactive Ingredients:
croscarmellose sodium
FD&C Blue No. 1
FD&C Red No. 3
magnesium stearate
gelatin
sodium lauryl sulfate
titanium dioxide
povidone k90
pregelatinized corn starch
silicon dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0177 Amerisource Health Services

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)